Saqib Islam - Net Worth and Insider Trading
Saqib Islam Net Worth
The estimated net worth of Saqib Islam is at least $46 Million dollars as of 2024-12-27. Saqib Islam is the CEO of SpringWorks Therapeutics Inc and owns about 1,014,368 shares of SpringWorks Therapeutics Inc (SWTX) stock worth over $38 Million. Saqib Islam is the EVP, Chief Strat & Port. Off. of Alexion Pharmaceuticals Inc and owns about 43,799 shares of Alexion Pharmaceuticals Inc (ALXN) stock worth over $8 Million. Saqib Islam is also the Director of Passage Bio Inc and owns about 5,000 shares of Passage Bio Inc (PASG) stock worth over $3,300. Details can be seen in Saqib Islam's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Saqib Islam has not made any transactions after 2024-12-02 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Saqib Islam
Saqib Islam Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Saqib Islam owns 7 companies in total, including ARYA Sciences Acquisition Corp III (ARYA) , Passage Bio Inc (PASG) , and SpringWorks Therapeutics Inc (SWTX) among others .
Click here to see the complete history of Saqib Islam’s form 4 insider trades.
Insider Ownership Summary of Saqib Islam
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| ARYA | ARYA Sciences Acquisition Corp III | 2020-08-06 | director |
| PASG | Passage Bio Inc | 2020-03-03 | director |
| SWTX | SpringWorks Therapeutics Inc | 2024-12-02 | director & Chief Executive Officer |
 | | 2016-02-29 | EVP & Chief Strat & Port. Off. |
| | 2020-12-03 | director |
| | 2020-08-06 | director |
| | 2020-12-03 | director |
Saqib Islam Latest Holdings Summary
Saqib Islam currently owns a total of 3 stocks. Among these stocks, Saqib Islam owns 1,014,368 shares of SpringWorks Therapeutics Inc (SWTX) as of December 2, 2024, with a value of $38 Million and a weighting of 82.49%. Saqib Islam owns 43,799 shares of Alexion Pharmaceuticals Inc (ALXN) as of February 29, 2016, with a value of $8 Million and a weighting of 17.5%. Saqib Islam also owns 5,000 shares of Passage Bio Inc (PASG) as of March 3, 2020, with a value of $3,300 and a weighting of 0.01%.
Latest Holdings of Saqib Islam
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| SWTX | SpringWorks Therapeutics Inc | 2024-12-02 | 1,014,368 | 37.14 | 37,673,628 |
| ALXN | Alexion Pharmaceuticals Inc | 2016-02-29 | 43,799 | 182.50 | 7,993,318 |
| PASG | Passage Bio Inc | 2020-03-03 | 5,000 | 0.66 | 3,300 |
Holding Weightings of Saqib Islam
Saqib Islam Form 4 Trading Tracker
According to the SEC Form 4 filings, Saqib Islam has made a total of 8 transactions in SpringWorks Therapeutics Inc (SWTX) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in SpringWorks Therapeutics Inc is the sale of 49,000 shares on December 2, 2024, which brought Saqib Islam around $2 Million.
According to the SEC Form 4 filings, Saqib Islam has made a total of 0 transactions in Alexion Pharmaceuticals Inc (ALXN) over the past 5 years. The most-recent trade in Alexion Pharmaceuticals Inc is the sale of 905 shares on February 29, 2016, which brought Saqib Islam around $125,714.
According to the SEC Form 4 filings, Saqib Islam has made a total of 1 transactions in Passage Bio Inc (PASG) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Passage Bio Inc is the acquisition of 5,000 shares on March 3, 2020, which cost Saqib Islam around $90,000.
Insider Trading History of Saqib Islam
- 1
Saqib Islam Trading Performance
GuruFocus tracks the stock performance after each of Saqib Islam's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Saqib Islam is 22.05%. GuruFocus also compares Saqib Islam's trading performance to market benchmark return within the same time period. The performance of stocks bought by Saqib Islam within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Saqib Islam's insider trading performs compared to the benchmark.
Performance of Saqib Islam
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -27.05 | | | | | |
| Relative Return to S&P 500(%) | -9.91 | | | | | |
Saqib Islam Ownership Network
Saqib Islam Owned Company Details
What does ARYA Sciences Acquisition Corp III do?
Who are the key executives at ARYA Sciences Acquisition Corp III?
Saqib Islam is the director of ARYA Sciences Acquisition Corp III. Other key executives at ARYA Sciences Acquisition Corp III include director & 10 percent owner & Chief Executive Officer Adam Leo Stone , director & 10 percent owner & Chief Financial Officer Michael Seth Altman , and 10 percent owner Arya Sciences Holdings Iii .
ARYA Sciences Acquisition Corp III (ARYA) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of ARYA Sciences Acquisition Corp III (ARYA) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of ARYA Sciences Acquisition Corp III (ARYA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
ARYA Sciences Acquisition Corp III (ARYA)'s detailed insider trading history can be found in Insider Trading Tracker table.
ARYA Sciences Acquisition Corp III Insider Transactions
Saqib Islam Mailing Address
Above is the net worth, insider trading, and ownership report for Saqib Islam. You might contact Saqib Islam via mailing address: Alexion Pharmaceuticals, 352 Knotter Drive, Cheshire Ct 06410.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
